NCT06328439View on ClinicalTrials.gov

A Study to Evaluate ANS014004 in Subjects With Locally Advanced or Metastatic Solid Tumors

PHASE1RecruitingINTERVENTIONAL
Enrollment

264

Participants

Timeline

Start Date

May 19, 2024

Primary Completion Date

December 31, 2027

Study Completion Date

January 31, 2028

Conditions
Locally Advanced or Metastatic Solid Tumors
Interventions
DRUG

ANS014004

Specification: 7.5mg; 30mg QD/BID Oral

Trial Locations (1)

Unknown

RECRUITING

Shanghai Chest Hospital, Shanghai

All Listed Sponsors
collaborator

Shanghai Chest Hospital

OTHER

collaborator

Hunan Cancer Hospital

OTHER

collaborator

Henan Cancer Hospital

OTHER_GOV

collaborator

Zhejiang Cancer Hospital

OTHER

collaborator

Peking University Cancer Hospital & Institute

OTHER

lead

Avistone Biotechnology Co., Ltd.

INDUSTRY